0

Addressing a Prominent Health Burden Using Real World Evidence: Management of Heart Failure with Preserved Ejection Fraction

Heart Failure: Common, Debilitating and Growing Public Health Issue Heart failure (HF) is a complex, debilitating syndrome affecting an estimated 63 million people worldwide (GBD 2016). Its impact on patients and health systems continues to increase in tandem with rising… Continue Reading

0

How Artificial Intelligence and Real World Data Can Improve the Management of Type 2 Diabetes: A Case Study

See how Veradigm, a business unit of Allscripts focused on generating data-driven healthcare insights using EHR data applied artificial intelligence to EHRs to improve therapeutic management of patients with concordant comorbidities who are living with type 2 diabetes. Continue Reading

0

Real-world evidence and value-based contracting – swipe left or swipe right?

As biopharma makes the shift toward a personalized healthcare system, it is also transitioning towards a pipeline full of innovative, high-cost therapies. We are moving to a value-based system, with two of the biggest ideas for this decade becoming more… Continue Reading

0

Key Elements of a Real-World Evidence Generation Plan: Integration of Product Support Activities

Shelby CormanPharmerit International Real-world evidence is a key component of value demonstration for pharmaceuticals, diagnostic agents, and medical devices throughout the product lifecycle. Planning for real-world evidence needs early in the pre-launch period can allow for seamless integration of health… Continue Reading

0

Benchmarking Survey: Can we reduce procurement time in HEOR & RWE?

As healthcare moves towards an increased focus on outcomes and value, health economics & outcomes research (HEOR) and real-world evidence (RWE) are being used to guide value-based decisions, improve outcomes, reduce costs, and achieve market access. This move toward new… Continue Reading